FASLODEX FULVESTRANT 250MG/5ML – 1

Faslodex (generic name: Fulvestrant) is a medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is particularly indicated for patients whose cancer has progressed following anti-estrogen therapy, such as tamoxifen. Faslodex works as an estrogen receptor antagonist, meaning it binds to estrogen receptors in breast cancer cells, blocking the effects of estrogen, which can promote the growth of these cancer cells.

The drug is administered via intramuscular injection, typically in a dosage of 250 mg per 5 ml. It is often used in combination with other therapies or as a single agent in advanced breast cancer cases. Faslodex is essential for managing hormone-sensitive tumors and can help slow disease progression, improve symptoms, and enhance the quality of life for patients with advanced breast cancer.